FDA Says Allergan Misleads Public On Eyelash Drug
The U.S. Food and Drug Administration has told Allergan Inc. that it has made misleading claims and downplayed potential side effects about its drug Latisse, used to lengthen and darken eyelashes....To view the full article, register now.
Already a subscriber? Click here to view full article